Antenatal Steroid Exposure and Neural Control of Blood Pressure
Antenatal Steroid Exposure and Neural Control of Blood Pressure
批准号:
8381684
负责人:
JAMES C. ROSE
金额:
$15.62万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-20 至 2016-08-31
关键词:
AdolescentAgeAge-MonthsAnimalsAttenuatedAutonomic DysfunctionAwardBaroreflexBetamethasoneBlood PressureBrainCardiacCardiovascular systemDevelopmentDorsalEnzymesEquilibriumEventFemaleFundingGlucocorticoidsHeart RateHuman ResourcesHypertensionImpairmentInfusion proceduresInstructionKidneyMetabolismModelingNucleus solitariusOrganPeptidesPredispositionPregnancyProcessRenin-Angiotensin SystemRisk FactorsRoleSheepSteroidsStructure of choroid plexusTherapeutic InterventionTissuesfetal programmingheart rate variabilityhuman subjectmalemortalityneuroregulationoffspringpostnatalpregnantprenatalpressureprogramsreceptorreceptor expression
中文摘要
计划发起人确定在怀孕80天时给怀孕的母羊使用糖皮质激素
导致6个月大的后代血压升高,可能是由于广泛的
对肾素血管紧张素系统(RAS)的影响。激素暴露对血管紧张素转换酶的影响
似乎特定于每个组织,在男性和女性中有所不同,但Ang II相对于Ang-(1-7)的偏爱是
在续签申请中要探索的总体假设。患有产前类固醇的青少年
暴露(项目4)显示心率变异性(HRV)降低,但没有升高压力,提示改变
青年受试者存在自主神经功能。在项目3中,我们展示了压力感受器反射的敏感性
(BRS)用于控制心率和HRV,是自主神经控制的重要指标,也是高血压的危险因素
靶器官损害和死亡率增加,在血压升高之前受损
显示了人类受试者和羊的胎儿编程模型之间的直接相似之处。在绵羊身上,
ATI受体阻滞剂可显著减轻或逆转BRS损伤,从而支持
在暴露的动物中夸大了血管紧张素转换酶的影响。Ang-(1-7)的保护作用被证明是不存在的
暴露的动物减少,导致雄性和雌性的BRS损伤。新的
初步研究表明,Ang II的贡献增加,Ang-(1-7)的损失对控制
孤束核(NTS)内的BRS。我们认为Ang II的表达升高,或
NTS内Ang-(1-7)或其受体减少是导致高血压的自主神经功能障碍的基础
产前应用类固醇后的血压和靶器官损害。目标1:表达
受体,Ang II和Ang-(1-7)形成/代谢的处理酶,或体内的多肽水平
绵羊经前处理后第四脑室的延髓背侧包括NTS和脉络丛的改变
在血压升高、肾功能或心功能不全之前或同时服用倍他米松
(出生后6周至6个月之间)?目标2:在NTS中BRS的调节是否向Ang II转移
6周龄裸露的绵羊?目的3:Will阻断大鼠第四脑室Ang-(1-7)受体
控制绵羊损害BRS,并开始增加压力,以模拟产前类固醇暴露?
目的4:血管紧张素-(1-7)或血管紧张素转换酶拮抗剂(ATI)能否纠正受损的BRS,
接触类固醇会增加血压和肾脏表现吗?
相关性(请参阅说明):
该项目将提供有关大脑机制的信息,这些机制涉及到增加对癌症的易感性
孕期接触类固醇的动物自主神经功能障碍。了解所涉及的机制
在改变Ang II和Ang-(1-7)的平衡中将对控制高血压的发展具有重要意义
高血压和靶器官损害与产前激素暴露有关,可能提供潜在的
对人类受试者随后的心血管问题的治疗干预。
英文摘要
Program invesfigators established that glucocorticoid administration to pregnant ewes at 80 d gestation
results in elevated blood pressure in offspring as eariy as 6 months of age, likely as a result of widespread
effects on the renin-angiotensin system (RAS). The changes in the RAS resulfing from steroid exposure
appear specific to each tissue and differ in males and females, but a shift in favor Ang II over Ang-(1-7) is
the overall hypothesis to be explored in the renewal applicafion. Adolescents with antenatal steroid
exposure (Project 4) show reduced heart rate variability (HRV) without elevated pressure, suggesfing altered
autonomic function exists in the young human subjects. In Project 3, we show that baroreflex sensitivity
(BRS) for control of heart rate and HRV, important indicators of autonomic control and risk factors for higher
target organ damage and increased mortality, are impaired preceding the elevafion in blood pressure
showing direct parallels between the human subjects and the sheep model of fetal programming. In sheep,
the BRS impairments are attenuated or reversed acutely with ATi receptor blockade, supporting a role for
exaggerated Ang tl effects in exposed animals. Protecfive effects of Ang-(1-7) were shown to be absent or
reduced in exposed animals, contributing to the BRS impairment in both males and females. New
preliminary studies reveal the increased contribution of Ang II and loss of Ang-(1-7) for control of
BRS within the nucleus tractus solitarius (NTS). We propose that elevated expression of Ang II, or
decreased Ang-(1-7) or its receptor in the NTS underlies the autonomic dysfunction predisposing to higher
blood pressure and target organ damage following antenatal steroid exposure. Aim 1: is expression of
receptors, processing enzymes for Ang II and Ang-(1-7) formation/ metabolism, or peptide levels in the
dorsal medulla including NTS and choroid plexus of the 4th ventricle altered in sheep treated antenatally
with betamethasone, prior to or coincident with increased blood pressure, renal or cardiac dysfuncfion
(between 6 wks and 6 months post-natal)? Aim 2: is regulafion of the BRS shifted towards Ang II in the NTS
of exposed sheep at 6 wks of age? Aim 3: will blockade ofAng-(1-7) receptors in brain 4th ventricle of
control sheep impair BRS and initiate an increase in pressure to mimic antenatal steroid exposure?
Aim 4: will Ang-(1-7) or an ATi antagonist infusion via 4th ventricle correct the impaired BRS,
increased blood pressure and renal manifestations of steroid exposure?
RELEVANCE (See Instructions):
The project will provide informafion on the brain mechanisms involved in the increased susceptibility to
autonomic dysfuncfion in animals exposed to antenatal steroids. Understanding the mechanisms involved
in altering the balance of Ang II and Ang-(1-7) will be important to controlling the development of the
hypertension and target organ damage related to the antenatal steroid exposure and may provide potential
therapeutic interventions for the subsequent cardiovascular problems in human subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:7005940
-
项目类别:
-
资助金额:$5.92万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids Exposure and Adipose Tissue Renin-Angiotensin-System Function
-
批准号:8381682
-
项目类别:
-
资助金额:$19.52万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids and Cardiometabolic Risk
-
批准号:8712519
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
-
批准号:9264075
-
项目类别:
-
资助金额:$46.76万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
-
批准号:8918005
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Critique of the Overall Program Project Application
-
批准号:7012101
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids and Cardiometabolic Risk
-
批准号:8381685
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
ANIMAL CORE
-
批准号:8381688
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:8712515
-
项目类别:
-
资助金额:$143.36万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroid Exposure and Neural Control of Blood Pressure
-
批准号:8712518
-
项目类别:
-
资助金额:$14.92万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7280921
-
项目类别:
-
资助金额:$103.81万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7683209
-
项目类别:
-
资助金额:$126.85万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin Syst
-
批准号:7005935
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroid Exposure and Neural Control of Blood Pressure
-
批准号:8212815
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7273360
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:7112462
-
项目类别:
-
资助金额:$97.11万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Prenatal Events-Postnatal Consequences
-
批准号:8531999
-
项目类别:
-
资助金额:$136.85万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
Antenatal Steroids Exposure and Adipose Tissue Renin-Angiotensin-System Function
-
批准号:8918006
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
-
批准号:8712516
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
ANIMAL CORE
-
批准号:8918010
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2005
-
负责人:JAMES C. ROSE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: